TWO SIGMA INVESTMENTS, LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$622,123
-31.0%
347,555
+31.0%
0.00%
-33.3%
Q4 2022$902,047
-27.7%
265,308
+16.2%
0.00%
-25.0%
Q3 2022$1,247,000
-73.0%
228,335
-77.7%
0.00%
-73.3%
Q2 2022$4,617,000
-44.0%
1,023,752
-8.4%
0.02%
-37.5%
Q1 2022$8,239,000
+29.6%
1,117,925
+13.0%
0.02%
+71.4%
Q4 2021$6,359,000
-0.4%
989,031
-9.8%
0.01%0.0%
Q3 2021$6,383,000
-26.9%
1,096,683
+29.6%
0.01%
-30.0%
Q2 2021$8,732,000
-44.4%
846,118
-43.3%
0.02%
-51.2%
Q1 2021$15,703,000
+2424.6%
1,492,642
+3611.9%
0.04%
+1950.0%
Q4 2020$622,000
-96.7%
40,212
-96.9%
0.00%
-97.0%
Q3 2020$18,800,000
+321.1%
1,287,652
+446.2%
0.07%
+204.5%
Q2 2020$4,465,000
-46.9%
235,734
-46.1%
0.02%
-67.6%
Q1 2020$8,407,000
-41.8%
437,622
-41.9%
0.07%
+58.1%
Q4 2019$14,441,000
+6809.6%
753,334
+3368.7%
0.04%
+4200.0%
Q3 2019$209,000
-43.7%
21,718
-64.9%
0.00%0.0%
Q2 2019$371,000
-81.7%
61,904
-82.1%
0.00%
-85.7%
Q1 2019$2,025,000
-64.6%
346,787
-43.3%
0.01%
-68.2%
Q4 2018$5,727,000
-15.7%
611,153
+53.2%
0.02%
+15.8%
Q3 2018$6,794,000
-20.8%
398,957
-21.0%
0.02%
-26.9%
Q2 2018$8,577,000
+424.3%
504,809
+314.2%
0.03%
+420.0%
Q1 2018$1,636,000
+602.1%
121,888
+403.3%
0.01%
+400.0%
Q4 2017$233,000
+55.3%
24,220
+76.8%
0.00%0.0%
Q3 2017$150,00013,7000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders